Screening for Diabetes and Prediabetes in Cystic Fibrosis using a Non-fasting 50-gram 1 Hour Oral Glucose Challenge Test
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
Objectives: Cystic fibrosis related diabetes (CFRD) affects nearly half of adults with CF, but screening rates with the recommended OGTT are low. We evaluated the utility of a non-fasting, 50g 1-hour oral glucose challenge test (GCT) as first-line screening for CFRD and pre-CFRD. The objectives were to define a cutoff that provides high sensitivity and reasonable specificity, and to determine how the GCT compares to other opportunistic tests. Research Design and Methods: Participants with cystic fibrosis (CF) ≥10 years old, without known diabetes, had baseline random plasma and capillary glucose (RPG, RCG), then underwent an in-clinic GCT for collection of 1-hour plasma glucose (GCTpl). This was followed by hemoglobin A1c (HbA1c) and OGTT on a separate day. Receiver operating characteristic (ROC) curves were generated for identifying CFRD and pre-CFRD. Results: Of 185 participants, 94 had normal glucose tolerance, 81 had pre-CFRD, and 10 had CFRD. For detecting pre-CFRD or CFRD, GCTpl had an area under the ROC curve (ROC-AUC) of 0.73 (95% CI 0.65-0.80), higher than ROC-AUCs for RPG of 0.56 ((0.48-0.65), p=0.003), RCG of 0.55 ((0.46=0.63), p=0.002), and HbA1c of 0.62 ((0.53-0.67), p=0.02). The ROC-AUC for detecting CFRD was 0.75 (0.64-0.86) for GCTpl, 0.64 (0.42-0.87) for RPG, and 0.56 (0.39-0.73) for HbA1c. A GCTpl of 147 mg/dL provides 90% sensitivity and 58% specificity for detecting CFRD and could reduce the OGTTs needed by 56%. Conclusion: The GCT offers a practical, in-clinic method for CFRD screening. This spares low-risk individuals from OGTT, while maintaining high sensitivity for CFRD.
Fields of Study & Subjects
Cystic Fibrosis Research Advances
Diabetes Management and Research
Pancreatic function and diabetes
Publication details
- Publication date
- 30 March 2026
- Language
- EN